555 related articles for article (PubMed ID: 15365996)
41. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach.
Gille JJ; Hogervorst FB; Pals G; Wijnen JT; van Schooten RJ; Dommering CJ; Meijer GA; Craanen ME; Nederlof PM; de Jong D; McElgunn CJ; Schouten JP; Menko FH
Br J Cancer; 2002 Oct; 87(8):892-7. PubMed ID: 12373605
[TBL] [Abstract][Full Text] [Related]
42. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT
J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610
[TBL] [Abstract][Full Text] [Related]
43. Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia.
Zavodna K; Bujalkova M; Krivulcik T; Alemayehu A; Skorvaga M; Marra G; Fridrichova I; Jiricny J; Bartosova Z
Neoplasma; 2006; 53(4):269-76. PubMed ID: 16830052
[TBL] [Abstract][Full Text] [Related]
44. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
Wagner A; Barrows A; Wijnen JT; van der Klift H; Franken PF; Verkuijlen P; Nakagawa H; Geugien M; Jaghmohan-Changur S; Breukel C; Meijers-Heijboer H; Morreau H; van Puijenbroek M; Burn J; Coronel S; Kinarski Y; Okimoto R; Watson P; Lynch JF; de la Chapelle A; Lynch HT; Fodde R
Am J Hum Genet; 2003 May; 72(5):1088-100. PubMed ID: 12658575
[TBL] [Abstract][Full Text] [Related]
45. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
[TBL] [Abstract][Full Text] [Related]
46. Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis.
Alazzouzi H; Domingo E; González S; Blanco I; Armengol M; Espín E; Plaja A; Schwartz S; Capella G; Schwartz S
Hum Mol Genet; 2005 Jan; 14(2):235-9. PubMed ID: 15563510
[TBL] [Abstract][Full Text] [Related]
47. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.
de Leon MP; Pedroni M; Benatti P; Percesepe A; Di Gregorio C; Foroni M; Rossi G; Genuardi M; Neri G; Leonardi F; Viel A; Capozzi E; Boiocchi M; Roncucci L
Gut; 1999 Jul; 45(1):32-8. PubMed ID: 10369701
[TBL] [Abstract][Full Text] [Related]
48. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population.
Lin KM; Shashidharan M; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lanspa SJ; Lemon SJ; Watson P; Lynch HT
Dis Colon Rectum; 1998 Apr; 41(4):428-33. PubMed ID: 9559626
[TBL] [Abstract][Full Text] [Related]
49. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing.
Terdiman JP; Gum JR; Conrad PG; Miller GA; Weinberg V; Crawley SC; Levin TR; Reeves C; Schmitt A; Hepburn M; Sleisenger MH; Kim YS
Gastroenterology; 2001 Jan; 120(1):21-30. PubMed ID: 11208710
[TBL] [Abstract][Full Text] [Related]
50. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer.
Berends MJ; Hollema H; Wu Y; van Der Sluis T; Mensink RG; ten Hoor KA; Sijmons RH; de Vries EG; Pras E; Mourits MJ; Hofstra RM; Buys CH; Kleibeuker JH; van Der Zee AG
Int J Cancer; 2001 May; 92(3):398-403. PubMed ID: 11291077
[TBL] [Abstract][Full Text] [Related]
51. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer.
Casey G; Lindor NM; Papadopoulos N; Thibodeau SN; Moskow J; Steelman S; Buzin CH; Sommer SS; Collins CE; Butz M; Aronson M; Gallinger S; Barker MA; Young JP; Jass JR; Hopper JL; Diep A; Bapat B; Salem M; Seminara D; Haile R;
JAMA; 2005 Feb; 293(7):799-809. PubMed ID: 15713769
[TBL] [Abstract][Full Text] [Related]
52. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer.
Renkonen E; Zhang Y; Lohi H; Salovaara R; Abdel-Rahman WM; Nilbert M; Aittomaki K; Jarvinen HJ; Mecklin JP; Lindblom A; Peltomaki P
J Clin Oncol; 2003 Oct; 21(19):3629-37. PubMed ID: 14512394
[TBL] [Abstract][Full Text] [Related]
53. MLH1 and MSH2 mutations in Colombian families with hereditary nonpolyposis colorectal cancer (Lynch syndrome)--description of four novel mutations.
Giraldo A; Gómez A; Salguero G; García H; Aristizábal F; Gutiérrez O; Angel LA; Padrón J; Martínez C; Martínez H; Malaver O; Flórez L; Barvo R
Fam Cancer; 2005; 4(4):285-90. PubMed ID: 16341804
[TBL] [Abstract][Full Text] [Related]
54. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.
Pucciarelli S; Agostini M; Viel A; Bertorelle R; Russo V; Toppan P; Lise M
Dis Colon Rectum; 2003 Mar; 46(3):305-12. PubMed ID: 12626904
[TBL] [Abstract][Full Text] [Related]
55. Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes.
Pensotti V; Radice P; Presciuttini S; Calistri D; Gazzoli I; Grimalt Perez A; Mondini P; Buonsanti G; Sala P; Rossetti C; Ranzani GN; Bertario L; Pierotti MA
Genes Chromosomes Cancer; 1997 Jul; 19(3):135-42. PubMed ID: 9218993
[TBL] [Abstract][Full Text] [Related]
56. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing.
Christensen M; Katballe N; Wikman F; Primdahl H; Sørensen FB; Laurberg S; Ørntoft TF
Cancer; 2002 Dec; 95(11):2422-30. PubMed ID: 12436451
[TBL] [Abstract][Full Text] [Related]
57. Genetic analysis of microsatellite markers in patients from hereditary nonpolyposis colorectal cancer (HNPCC) families.
Smolarz B; Romanowicz-Makowska H; Langner E; Kozlowska E; Kulig A; Dziki A
Exp Oncol; 2004 Sep; 26(3):205-9. PubMed ID: 15494688
[TBL] [Abstract][Full Text] [Related]
58. Optimization of experimental conditions for RNA-based sequencing of MLH1 and MSH2 genes.
Jakubowska A; Górski B; Kurzawski G; Debniak T; Hadaczek P; Cybulski C; Kladny J; Oszurek O; Scott RJ; Lubinski J
Hum Mutat; 2001; 17(1):52-60. PubMed ID: 11139242
[TBL] [Abstract][Full Text] [Related]
59. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
[TBL] [Abstract][Full Text] [Related]
60. Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant.
Berends MJ; Wu Y; Sijmons RH; Mensink RG; van der Sluis T; Hordijk-Hos JM; de Vries EG; Hollema H; Karrenbeld A; Buys CH; van der Zee AG; Hofstra RM; Kleibeuker JH
Am J Hum Genet; 2002 Jan; 70(1):26-37. PubMed ID: 11709755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]